Registry of Parkinson's disease patients with SNCA gene variants in China
Official title: The Chinese Parkinson's Disease With SNCA Variants Registry
Run by Xiangya Hospital of Central South University · NCT03523052 · Data updated 2026-11-12
This study is trying to gather information from people with Parkinson's disease in China who have certain gene changes to better understand how these changes affect their symptoms and the disease's progression.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 3000 (estimated) |
| Sponsor | Xiangya Hospital of Central South University Academic / other |
| Locations | 1 site (Changsha, Hunan) |
| Status | Recruiting |
| Started | February 1, 2017 |
| Main results expected | February 1, 2027 |
| Study ends | February 1, 2027 |
| Registry record updated | May 29, 2018 |
| Trial ID | NCT03523052 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients diagnosed with Parkinson's disease who have tested positive for SNCA gene variants.
✕Probably not a fit
Patients without a diagnosis of Parkinson's disease or those who do not have SNCA gene variants may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The Chinese PD-SNCA Registry aims to create a comprehensive database of patients diagnosed with Parkinson's disease who have specific variants of the SNCA gene. This observational study will collect peripheral blood samples from participants to identify SNCA gene variants and assess their clinical manifestations using various standardized neurological scales and tests. Additionally, the study will analyze blood biomarkers associated with Parkinson's disease to better understand the condition's progression and characteristics in the Chinese population.
Why it matters
Potential benefit: If successful, this registry could enhance understanding of Parkinson's disease and lead to improved diagnosis and treatment strategies for patients with SNCA gene variants.
How similar studies have gone: While the study focuses on a specific genetic variant in a defined population, similar registries have shown promise in enhancing understanding of genetic influences on Parkinson's disease.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients diagnosed with PD by the United Kingdom Parkinson's Disease Society Brain Bank clinical diagnostic criteria or other standard criteria; PD patients detected with positive SNCA variants Exclusion Criteria: \-
Where it's running
-
Xiangya Hospital of Central South University
Changsha, Hunan, China Recruiting
Study contacts
- Study coordinator: Jifeng Guo, Ph.D.
- Email: guojifeng2003@163.com
- Phone: +8613974936815
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Tributyrin for PSP: a virtual, early-phase study
This study tests whether tributyrin is safe and tolerable in people with Progressive Supranuclear Palsy who are 45 or older, using virtual visits.
-
A look at why Lewy body conditions cause visual hallucinations
This study tests brain‑imaging in people with Lewy body diseases who do or don’t experience visual hallucinations, and in healthy volunteers, to see how brain networks might create these images.
-
How physical activity might help people with Parkinson’s disease who have DBS-STN implants
This study tests whether adding regular physical activity can help people with Parkinson’s who have DBS-STN stimulation by trying a structured physiotherapy approach alongside standard care.
-
Can hippotherapy improve mobility, gait, balance, and quality of life in people with Parkinson's disease?
This pilot trial tests whether adding horse-assisted therapy to standard rehab helps mobility, gait, balance, and perceived health in adults with Parkinson's disease.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.